286 related articles for article (PubMed ID: 29538593)
41. [Clinical and histopathologic analysis of superficial tissue proliferation following the implantation of keratoprosthesis].
Dong Y; Huang YF; Liu Q; DU GP
Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):431-5. PubMed ID: 21756746
[TBL] [Abstract][Full Text] [Related]
42. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
43. [Mid- and Longterm Experiences with the Boston-Keratoprosthesis. The Cologne and Salzburg Perspective].
Schaub F; Bachmann BO; Seyeddain O; Moussa S; Reitsamer HA; Cursiefen C
Klin Monbl Augenheilkd; 2017 Jun; 234(6):770-775. PubMed ID: 28586930
[No Abstract] [Full Text] [Related]
44. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
45. Anterior segment optical coherence tomography for the diagnosis of corneal dystrophies according to the IC3D classification.
Siebelmann S; Scholz P; Sonnenschein S; Bachmann B; Matthaei M; Cursiefen C; Heindl LM
Surv Ophthalmol; 2018; 63(3):365-380. PubMed ID: 28801092
[TBL] [Abstract][Full Text] [Related]
46. International results with the Boston type I keratoprosthesis.
Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
[TBL] [Abstract][Full Text] [Related]
47. Russian Keratoprosthesis in Stevens-Johnson Syndrome.
Ma X; Xiang R; Meng X; Qin L; Wu Y; Tain L; Jiang Y; Huang Y; Wang L
Cornea; 2017 Mar; 36(3):304-309. PubMed ID: 27941382
[TBL] [Abstract][Full Text] [Related]
48. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results.
Rudnisky CJ; Belin MW; Todani A; Al-Arfaj K; Ament JD; Zerbe BJ; Ciolino JB;
Ophthalmology; 2012 May; 119(5):951-5. PubMed ID: 22361316
[TBL] [Abstract][Full Text] [Related]
50. [Long-term outcomes of Boston keratoprosthesis].
Mori Y; Nejima R; Minami K; Miyata K; Kamiya K; Fukud M
Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):35-43. PubMed ID: 23424974
[TBL] [Abstract][Full Text] [Related]
51. ULTRA-WIDEFIELD IMAGING OF POSTERIOR SEGMENT PATHOLOGY IN THE SETTING OF THE BOSTON KERATOPROSTHESIS.
Kornberg DL; Yannuzzi NA; Klufas MA; DʼAmico DJ; Orlin A; Kiss S
Retina; 2016 Jun; 36(6):1101-10. PubMed ID: 26536101
[TBL] [Abstract][Full Text] [Related]
52. En-face optical coherence tomography as a novel tool for exploring the ocular surface: a pilot comparative study to conventional B-scans and in vivo confocal microscopy.
Tahiri Joutei Hassani R; Liang H; El Sanharawi M; Brasnu E; Kallel S; Labbé A; Baudouin C
Ocul Surf; 2014 Oct; 12(4):285-306. PubMed ID: 25284774
[TBL] [Abstract][Full Text] [Related]
53. Retroprosthetic Membrane Formation in Boston Keratoprosthesis: A Case-Control-Matched Comparison of Titanium Versus PMMA Backplate.
Talati RK; Hallak JA; Karas FI; de la Cruz J; Cortina MS
Cornea; 2018 Feb; 37(2):145-150. PubMed ID: 29140862
[TBL] [Abstract][Full Text] [Related]
54. Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study.
Csorba A; Maka E; Maneschg OA; Szabó A; Szentmáry N; Csidey M; Resch M; Imre L; Knézy K; Nagy ZZ
BMC Ophthalmol; 2020 Feb; 20(1):73. PubMed ID: 32102651
[TBL] [Abstract][Full Text] [Related]
55. Corneal profile analysis after Descemet stripping endothelial keratoplasty and its relationship to postoperative hyperopic shift.
Holz HA; Meyer JJ; Espandar L; Tabin GC; Mifflin MD; Moshirfar M
J Cataract Refract Surg; 2008 Feb; 34(2):211-4. PubMed ID: 18242442
[TBL] [Abstract][Full Text] [Related]
56. Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1.
Geoffrion D; Robert MC; Chodosh J; Di Polo A; Harissi-Dagher M
Exp Eye Res; 2021 Jul; 208():108615. PubMed ID: 33971222
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal Evaluation of Wound Healing after Penetrating Corneal Injury: Anterior Segment Optical Coherence Tomography Study.
Zheng KK; Cai J; Rong SS; Peng K; Xia H; Jin C; Lu X; Liu X; Chen H; Jhanji V
Curr Eye Res; 2017 Jul; 42(7):982-986. PubMed ID: 28632029
[TBL] [Abstract][Full Text] [Related]
58. Experience with Boston keratoprosthesis type 1 in the developing world.
de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
[TBL] [Abstract][Full Text] [Related]
59. Boston type 1 keratoprosthesis outcomes in ocular burns.
Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
[TBL] [Abstract][Full Text] [Related]
60. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
